Autolus Therapeutics plc

Nasdaq:AUTL

Biological Products, (No Diagnostic Substances)·LONDON, X0

Financials

9 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

28 shown

Filed	Type	Description
1/26/26	Agreement	Entry into a Material Definitive Agreement	→
1/12/26	Reg FD	Regulation FD Disclosure	→
12/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/27/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/2/25	Other	Other Events	→
5/30/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/26/26	424B3	424B3	→
1/12/26	424B3	424B3	→
12/2/25	424B3	424B3	→
11/18/25	S-8	S-8	→
11/12/25	424B3	424B3	→
8/12/25	424B3	424B3	→
↓

Filing History(273 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001258

—

10.6 KB

SCHEDULE 13G/A

Feb 13, 2026

0001019056-26-000041

—

19.8 KB

424B3

Jan 26, 2026

0001730463-26-000021424B3

—

112.2 KB

8-K

Jan 26, 2026

0001730463-26-0000198-K

Jan 21, 2026

183.1 KB

424B3

Jan 12, 2026

0001730463-26-000013424B3

—

115.1 KB

8-K

Jan 12, 2026

0001730463-26-0000128-K

Jan 12, 2026

7.2 MB

SCHEDULE 13G/A

Dec 3, 2025

0001019056-25-000256

—

19.6 KB

424B3

Dec 2, 2025

0001730463-25-000097424B3

—

555.1 KB

8-K

Dec 2, 2025

0001730463-25-0000958-K

Dec 1, 2025

632.5 KB

S-8

Nov 18, 2025

0001193125-25-286209S-8

—

295.4 KB

SCHEDULE 13G

Nov 14, 2025

0001172661-25-005172

—

10.5 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-004821

—

11.3 KB

424B3

Nov 12, 2025

0001730463-25-000090424B3

—

1.5 MB

10-Q

Nov 12, 2025

0001730463-25-00008810-Q

Sep 30, 2025

8.8 MB

8-K

Nov 12, 2025

0001730463-25-0000818-K

Nov 12, 2025

5.6 MB

SCHEDULE 13G/A

Oct 6, 2025

0000902219-25-000361

—

15.0 KB

424B3

Aug 12, 2025

0001730463-25-000069424B3

—

10.2 MB

10-Q

Aug 12, 2025

0001730463-25-00006710-Q

Jun 30, 2025

17.5 MB

8-K

Aug 12, 2025

0001730463-25-0000648-K

Aug 12, 2025

4.0 MB

424B3

Jun 30, 2025

0001730463-25-000050424B3

—

128.1 KB

8-K

Jun 27, 2025

0001730463-25-0000468-K

Jun 26, 2025

193.2 KB

SCHEDULE 13G

Jun 25, 2025

0001019056-25-000184

—

18.2 KB

8-K

Jun 2, 2025

0001730463-25-0000438-K

Jun 2, 2025

47.8 MB

424B3

May 30, 2025

0001193125-25-132120424B3

—

28.4 KB

8-K

May 30, 2025

0001193125-25-1321118-K

May 23, 2025

179.1 KB

25 filings shown

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
11/14/24	SC 13G/A	SC 13G/A	→
11/14/24	SC 13G/A	SC 13G/A	→
11/12/24	SC 13G	SC 13G	→
11/8/24	SC 13G	SEC SCHEDULE 13G	→
10/25/24	SC 13D/A	AMENDMENT NO. 10 TO SCHEDULE 13D	→
↓

Autolus Therapeutics plc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(273 filings)

Ownership

Other Filings

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/3/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/6/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓